IBio, Inc. (IBIO) Produces A Vaccine Candidate For The Newly Emerged H7N9 Virus
iBio develops and offers product applications of its proprietary iBioLaunch and iBioModulator platforms. In addition, the company develops select vaccine candidates that have been derived from its iBioLaunch platform. Its technology utilizes transient gene expression in unmodified green plants... More »








